Table 9.
Proportion of Subjects Having FDA Mean Adhesion Score (MAS) >1 (≥75% to <90% Adhered, Some Edges Only Lifting off the Skin) or More Among Treatments
| Comparison | N | n | Proportion | 95% CI |
|---|---|---|---|---|
| Test 1 MAS > Reference MAS by 1 or more | 22 | 11 | 0.5000 (11/22) | 0.7269 |
| Reference MAS > Test 1 MAS by 1 or more | 22 | 0 | 0.0000 (0/22) | 0.0000 |
| Test 2 MAS > Reference MAS by 1 or more | 22 | 9 | 0.4091 (9/22) | 0.6322 |
| Reference MAS > Test 2 MAS by 1 or more | 22 | 0 | 0.0000 (0/22) | 0.0000 |
| Test 3 MAS > Reference MAS by 1 or more | 22 | 12 | 0.5455 (12/22) | 0.7714 |
| Reference MAS > Test 3 MAS by 1 or more | 22 | 0 | 0.0000 (0/22) | 0.0000 |
Notes: Reference (R): ZTLIDO® (lidocaine topical system). Test 1 (T1): Salonpas® (lidocaine patch 4%). Test 2 (T2): Aspercreme® (lidocaine patch 4%). Test 3 (T3): IcyHot® (lidocaine + menthol patch 4%/1%).
Abbreviations: CI, confidence interval; MAS, mean adhesion score; SD, standard deviation.